Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

ZimVie Inc. - Common Stock (NQ: ZIMV )

12.04 +0.06 (+0.50%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about ZimVie Inc. - Common Stock

< Previous 1 2 Next >
ZimVie Announces Upcoming Changes to Company's Board of Directors
From ZimVie Inc.
Via GlobeNewswire
ZimVie Reports Fourth Quarter and Full Year 2024 Financial Results
From ZimVie Inc.
Via GlobeNewswire
ZimVie to Report Fourth Quarter and Full-Year 2024 Financial Results on February 26, 2025
From ZimVie Inc.
Via GlobeNewswire
ZimVie Announces Publication of a Study Supporting the Benefits of Its Implant Surface Technologies
Data confirms ZimVie implants meet critical roughness criteria advantageous for long-term peri-implant health 
From ZimVie Inc.
Via GlobeNewswire
ZimVie Reports Third Quarter 2024 Financial Results
From ZimVie Inc.
Via GlobeNewswire
ZimVie to Present at the UBS Global Healthcare Conference
From ZimVie Inc.
Via GlobeNewswire
ZimVie to Report Third Quarter Financial Results on October 30, 2024
From ZimVie Inc.
Via GlobeNewswire
ZimVie Reports Second Quarter 2024 Financial Results
From ZimVie Inc.
Via GlobeNewswire
ZimVie Announces the Release of RealGUIDE® 5.4 Software Update
Latest Update for ZimVie’s RealGUIDE® Dental Implant Software Suite Introduces New Features to Drive Provider Efficiency and Savings 
From ZimVie Inc.
Via GlobeNewswire
ZimVie Announces FDA Clearance and U.S. Launch of GenTek® Restorative Components
Addition of Premium Restorative Components Enhances ZimVie’s End-to-End Implant Offerings 
From ZimVie Inc.
Via GlobeNewswire
ZimVie to Report Second Quarter Financial Results on August 1, 2024
From ZimVie Inc.
Via GlobeNewswire
ZimVie to Participate in Upcoming Investor Conferences
From ZimVie Inc.
Via GlobeNewswire
ZimVie Reports First Quarter 2024 Financial Results
From ZimVie Inc.
Via GlobeNewswire
ZimVie to Report First Quarter Financial Results on May 8, 2024
From ZimVie Inc.
Via GlobeNewswire
ZimVie Announces Closing of Sale of Spine Business
Completion of Sale to an Affiliate of H.I.G. Capital for $375 Million Establishes Pure-Play Dental Business 
From ZimVie Inc.
Via GlobeNewswire
ZimVie to Participate in the 23rd Annual Needham Virtual Healthcare Conference
From ZimVie Inc.
Via GlobeNewswire
ZimVie Reports Fourth Quarter and Full Year 2023 Financial Results
From ZimVie Inc.
Via GlobeNewswire
ZimVie to Report Fourth Quarter and Full-Year 2023 Financial Results on February 28, 2024
From ZimVie Inc.
Via GlobeNewswire
ZimVie Announces Launch of Next-Generation TSX® Implant in Japan
Newest implant innovation is designed for immediacy and peri-implant health 
From ZimVie Inc.
Via GlobeNewswire
ZimVie Announces Definitive Agreement to Sell Spine Business to H.I.G. Capital for $375 Million
From ZimVie Inc.
Via GlobeNewswire
ZimVie Announces Compatibility Between its Vital™ Spinal Fixation System and Brainlab Spine & Trauma Navigation
From ZimVie Inc.
Via GlobeNewswire
ZimVie Reports Third Quarter 2023 Financial Results and Provides Update to Annual Guidance
From ZimVie Inc.
Via GlobeNewswire
ZimVie Announces First U.S. Surgery with the 4.5mm Mobi-C® Cervical Disc
From ZimVie Inc.
Via GlobeNewswire
ZimVie Announces Over 2,000 Children Have Received The Tether™ VBT
From ZimVie Inc.
Via GlobeNewswire
ZimVie Announces the Launch of Azure™ Multi-Platform Product Solutions
New offerings expand ZimVie’s dental solutions for lab customers, enhancing selection and broadening the reach of the ZimVie portfolio 
From ZimVie Inc.
Via GlobeNewswire
ZimVie to Report Third Quarter 2023 Financial Results on November 1, 2023
From ZimVie Inc.
Via GlobeNewswire
ZimVie Announces the Recent Launch of Biotivity™ A/C Plus Membrane
New offering broadens ZimVie’s dental portfolio into the expanding growth factor biomaterials market 
From ZimVie Inc.
Via GlobeNewswire
ZimVie Announces FDA Approval to Launch Mobi-C® Hybrid Study
Decision clears the way for enrollment of U.S. patients in a groundbreaking clinical study of cervical arthroplasty adjacent to fusion 
From ZimVie Inc.
Via GlobeNewswire
ZimVie Expands Development Cooperation Agreement with Brainlab AG to Include Co-Marketing
From ZimVie Inc.
Via GlobeNewswire
ZimVie Announces FDA Approval for New Mobi-C® Implant
Smaller height implants in all Mobi-C footprints to address patient anatomy 
From ZimVie Inc.
Via GlobeNewswire
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.